Publikationen in Zusammenarbeit mit Forschern von Heinrich Heine University Düsseldorf (53)

2024

  1. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

    Science Immunology, Vol. 9, Núm. 91

2022

  1. Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

    Bone Marrow Transplantation

2021

  1. 1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans

    Translational psychiatry, Vol. 11, Núm. 1, pp. 182

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Risk Factors for Childhood Leukemia: Radiation and Beyond

    Frontiers in Public Health, Vol. 9

  4. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia

    Frontiers in Cell and Developmental Biology, Vol. 9

  5. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

    Leukemia, Vol. 35, Núm. 3, pp. 835-849

  6. Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

    Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2020

  1. An intact gut microbiome protects genetically predisposed mice against leukemia

    Blood, Vol. 136, Núm. 18, pp. 2003-2017

  2. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region with Cortical and Subcortical Morphology and Cognition

    JAMA Psychiatry, Vol. 77, Núm. 4, pp. 420-430

  3. Cell Fate Decisions: The Role of Transcript on Factors in Early B-cell Development and Leukemia

    BLOOD CANCER DISCOVERY, Vol. 1, Núm. 3, pp. 224-233

  4. Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions

    Drug Resistance Updates, Vol. 48

  5. Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study

    The Lancet Infectious Diseases, Vol. 20, Núm. 12, pp. 1409-1417

  6. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

    Molecular Psychiatry, Vol. 25, Núm. 3, pp. 584-602

2019

  1. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Epigenetic Priming in Cancer Initiation

    Trends in Cancer, Vol. 4, Núm. 6, pp. 408-417

  2. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis

    EMBO Journal, Vol. 37, Núm. 14

  3. Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL

    Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679

  4. T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology

    Molecular and Cellular Oncology, Vol. 5, Núm. 4

2017

  1. Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells

    Oncotarget, Vol. 8, Núm. 44, pp. 75797-75807